# Fundamental mechanism of ferroptosis: Three unanswered questions

**Authors:** Hanna Feinsod, Brent R. Stockwell

PMC · DOI: 10.70401/fos.2026.0015 · Ferroptosis and oxidative stress · 2026-03-14

## TL;DR

This paper highlights three unresolved questions about ferroptosis, a type of cell death linked to cancer and disease, that need answers to better understand and use it therapeutically.

## Contribution

The paper identifies three key unanswered questions about ferroptosis mechanisms, physiology, and interactions with other cell death types.

## Key findings

- The exact mechanism by which lipid peroxides trigger cell death during ferroptosis is unknown.
- The physiological role of ferroptosis across the human life cycle is not fully understood.
- How ferroptosis interacts with other regulated cell death pathways remains unclear.

## Abstract

Ferroptosis, an iron-dependent form of regulated cell death (RCD) driven by lipid peroxidation, has been extensively studied since its conceptualization in 2012 and has been suggested as a therapeutic target in many cancers and degenerative diseases. However, three fundamental questions remain unanswered about ferroptosis. First, the mechanisms by which cells execute death during ferroptosis remain elusive: The key role of lipid peroxides in triggering ferroptosis is established, but how this results in the death of a cell remains unclear. Second, the physiological role of ferroptosis throughout the human life cycle is unclear; currently, there is evidence for ferroptosis in early development, immunity, aging, and tumor suppression, but not in many other aspects of physiology. Third, and finally, the intersection between ferroptosis and other RCD modalities, such as apoptosis, necroptosis, pyroptosis, and autophagic cell death, is necessary for understanding how ferroptosis integrates into networks controlling cellular fate. Addressing these gaps in knowledge is essential for building a comprehensive understanding of this mode of cell death, as well as translating ferroptosis knowledge into effective therapeutics.

## Full-text entities

- **Genes:** Mboat2 (membrane bound O-acyltransferase domain containing 2) [NCBI Gene 67216] {aka 2810049G06Rik, LPCAT4, Moact2, Oact2}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, RIPK1 (receptor interacting serine/threonine kinase 1) [NCBI Gene 8737] {aka AIEFL, IMD57, RIP, RIP-1, RIP1}, Steap3 (STEAP family member 3) [NCBI Gene 68428] {aka 1010001D01Rik, Tsap6, pHyde}, ATL1 (atlastin GTPase 1) [NCBI Gene 51062] {aka AD-FSP, ATL-1, FSP1, HSN1D, SPG3, SPG3A}, BAK1 (BCL2 antagonist/killer 1) [NCBI Gene 578] {aka BAK, BAK-LIKE, BCL2L7, CDN1}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, ACSL3 (acyl-CoA synthetase long chain family member 3) [NCBI Gene 2181] {aka ACS3, FACL3, LACS 3, LACS3, PRO2194}, Esr1 (estrogen receptor 1 (alpha)) [NCBI Gene 13982] {aka ER, ER-alpha, ERa, ERalpha, ESR, Estr}, SCD (stearoyl-CoA desaturase) [NCBI Gene 6319] {aka FADS5, MSTP008, SCD1, SCDOS, hSCD1}, Scd1 (stearoyl-Coenzyme A desaturase 1) [NCBI Gene 20249] {aka Scd, Scd-1, ab}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, Bap1 (Brca1 associated protein 1) [NCBI Gene 104416] {aka 2300006C11Rik, mKIAA0272, uch-x4}, Slc7a11 (solute carrier family 7 (cationic amino acid transporter, y+ system), member 11) [NCBI Gene 26570] {aka 9930009M05Rik, sut, xCT}, LOX (lysyl oxidase) [NCBI Gene 4015] {aka AAT10}, CASP1 (caspase 1) [NCBI Gene 834] {aka ICE, IL1BC, P45}, GPX4 (glutathione peroxidase 4) [NCBI Gene 2879] {aka GPx-4, GSHPx-4, MCSP, PHGPx, SMDS, snGPx}, Trf (transferrin) [NCBI Gene 22041] {aka Cd176, HP, Tf, Tfn, hpx}, HSP90AA1 (heat shock protein 90 alpha family class A member 1) [NCBI Gene 3320] {aka EL52, HEL-S-65p, HSP86, HSP89A, HSP90A, HSP90N}, BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581] {aka BCL2L4}, NCOA4 (nuclear receptor coactivator 4) [NCBI Gene 8031] {aka ARA70, ELE1, PTC3, RFG}, SLC7A11 (solute carrier family 7 member 11) [NCBI Gene 23657] {aka CCBR1, xCT}, MAP1LC3A (microtubule associated protein 1 light chain 3 alpha) [NCBI Gene 84557] {aka ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3}, Fasn (fatty acid synthase) [NCBI Gene 14104] {aka A630082H08Rik, FAS}, Gpx4 (glutathione peroxidase 4) [NCBI Gene 625249] {aka GPx-4, GSHPx-4, PHGPx, mtPHGPx, snGPx}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}, PMAIP1 (phorbol-12-myristate-13-acetate-induced protein 1) [NCBI Gene 5366] {aka APR, NOXA}, LPCAT3 (lysophosphatidylcholine acyltransferase 3) [NCBI Gene 10162] {aka C3F, LPCAT, LPLAT 5, LPLAT12, LPSAT, MBOAT5}, Ar (androgen receptor) [NCBI Gene 11835] {aka Tfm}, Acsl4 (acyl-CoA synthetase long-chain family member 4) [NCBI Gene 50790] {aka 9430020A05Rik, ACS4, Facl4, Lacs4}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, NINJ1 (ninjurin 1) [NCBI Gene 4814] {aka NIN1, NINJURIN, hNINJ1}, CYCS (cytochrome c, somatic) [NCBI Gene 54205] {aka CYC, HCS, THC4}, RAB7A (RAB7A, member RAS oncogene family) [NCBI Gene 7879] {aka CMT2B, PRO2706, RAB7}, MLKL (mixed lineage kinase domain like pseudokinase) [NCBI Gene 197259] {aka hMLKL}, Lpcat3 (lysophosphatidylcholine acyltransferase 3) [NCBI Gene 14792] {aka C3f, Grcc3f, Lpcat, Lpeat, Lplat5, Lpsat}, Lox (lysyl oxidase) [NCBI Gene 16948] {aka TSC-160, rrg}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, RIPK3 (receptor interacting serine/threonine kinase 3) [NCBI Gene 11035] {aka RIP3}, BCL2L11 (BCL2 like 11) [NCBI Gene 10018] {aka BAM, BIM, BOD}, STEAP3 (STEAP3 metalloreductase) [NCBI Gene 55240] {aka AHMIO2, STMP3, TSAP6, dudlin-2, dudulin-2, pHyde}, Slc11a2 (solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2) [NCBI Gene 18174] {aka DCT1, DMT1, Nramp2, mk, van}, Fdxr (ferredoxin reductase) [NCBI Gene 14149] {aka AR}, Itpr3 (inositol 1,4,5-triphosphate receptor 3) [NCBI Gene 16440] {aka IP3R 3, IP3R-3, Ip3r3, Itpr-3, tf}, Atl1 (atlastin GTPase 1) [NCBI Gene 73991] {aka 4930435M24Rik, Adfsp, Fsp1, Spg3, Spg3a}, Trp53-ps (transformation related protein 53, pseudogene) [NCBI Gene 22060], ACSL4 (acyl-CoA synthetase long chain family member 4) [NCBI Gene 2182] {aka ACS4, FACL4, LACS4, MRX63, MRX68, XLID63}, BCL2L1 (BCL2 like 1) [NCBI Gene 598] {aka BCL-XL/S, BCL2L, BCLX, Bcl-X, PPP1R52}, Tfrc (transferrin receptor) [NCBI Gene 22042] {aka 2610028K12Rik, CD71, E430033M20Rik, Mtvr1, TFR, TFR1}, CASP9 (caspase 9) [NCBI Gene 842] {aka APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56}, SLC11A2 (solute carrier family 11 member 2) [NCBI Gene 4891] {aka AHMIO1, DCT1, DMT1, NRAMP2}, FASN (fatty acid synthase) [NCBI Gene 2194] {aka FAS, OA-519, SDR27X1}, Mboat1 (membrane bound O-acyltransferase domain containing 1) [NCBI Gene 218121] {aka 9130215M02Rik, LPEAT, LPEAT1, LPLAT 1, LPSAT, Moact1}, BBC3 (BCL2 binding component 3) [NCBI Gene 27113] {aka JFY-1, JFY1, PUMA}, Acsl3 (acyl-CoA synthetase long-chain family member 3) [NCBI Gene 74205] {aka 2610510B12Rik, Acs3, Facl3, LACS 3, Pro2194}
- **Diseases:** skin cancers (MESH:D012878), RCD (MESH:D003643), tumorigenesis (MESH:D063646), Alzheimer's and Parkinson's disease (MESH:D010300), ischemia-reperfusion injuries (MESH:D015427), degenerative diseases (MESH:D019636), MOMP (MESH:D015433), cancer (MESH:D009369), breast, cervical, and lung cancers (MESH:D001943), necrosis (MESH:D009336), inflammatory (MESH:D007249), Mixed Lineage Leukemia 4 deficiency (MESH:D015456)
- **Chemicals:** calcium (MESH:D002118), MUFAs (MESH:D005229), CoQ10H2 (-), fatty acid (MESH:D005227), Tricarboxylic Acid (MESH:D014233), Iron (MESH:D007501), CoQ10 (MESH:C024989), Nec-1 (MESH:C507699), Lipid (MESH:D008055), NADPH (MESH:D009249), lipid hydroperoxides (MESH:D008054), ROS (MESH:D017382), Cystine (MESH:D003553), polyunsaturated fatty acids (MESH:D005231), ubiquinone (MESH:D014451), glutamate (MESH:D018698), Cysteine (MESH:D003545), GSH (MESH:D005978), phospholipid (MESH:D010743), water (MESH:D014867), ubiquinol (MESH:C003741), Abivertinib (MESH:C000630672)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12987573/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12987573/full.md

## References

139 references — full list in the complete paper: https://tomesphere.com/paper/PMC12987573/full.md

---
Source: https://tomesphere.com/paper/PMC12987573